|
Volumn 14, Issue 6, 2013, Pages 454-455
|
The need for proportionate regulation of clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
CLINICAL TRIAL (TOPIC);
DRUG LABELING;
DRUG LEGISLATION;
EUROPEAN UNION;
FUNDING;
HEALTH ECONOMICS;
HUMAN;
HUMAN RIGHTS;
LETTER;
LICENSING;
MEDICAL DECISION MAKING;
PRIORITY JOURNAL;
RESPONSIBILITY;
SAFETY;
ACCESS TO INFORMATION;
CLINICAL TRIALS AS TOPIC;
COOPERATIVE BEHAVIOR;
DRUG APPROVAL;
EUROPE;
EUROPEAN UNION;
GOVERNMENT REGULATION;
HEALTH POLICY;
HUMANS;
INTERNATIONAL COOPERATION;
|
EID: 84876969202
PISSN: 14702045
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(13)70077-9 Document Type: Letter |
Times cited : (5)
|
References (7)
|